Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.28 | 3e-14 |
mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.34 | 3e-11 |
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |
mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-06 |
mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.16 | 0.001 |